Enhanced Kidney Targeting and Distribution of Tubuloids During Normothermic Perfusion

dc.contributor.authorMontagud Marrahí, Enrique
dc.contributor.authorRodriguez Gonzalo, Adriana
dc.contributor.authorLópez Aladid, Rubén
dc.contributor.authorLuque, Yosu
dc.contributor.authorRabadán Ros, Ruben
dc.contributor.authorCuadrado Payán, Elena
dc.contributor.authorBañón Maneus, Elisenda
dc.contributor.authorRovira Juárez, Jordi
dc.contributor.authorLazo Rodríguez, Marta
dc.contributor.authorAguilà, Oriol
dc.contributor.authorArana Aliaga, Carolt
dc.contributor.authorGarcía Busquets, Ainhoa
dc.contributor.authorHierro, Natalia
dc.contributor.authorPrudhomme, Thomas
dc.contributor.authorMusquera Felip, Mireia
dc.contributor.authorXia, Yun
dc.contributor.authorDiekmann, Fritz
dc.contributor.authorCampistol, Josep M
dc.contributor.authorRamírez Bajo, María José
dc.date.accessioned2025-11-14T06:07:02Z
dc.date.available2025-11-14T06:07:02Z
dc.date.issued2025-09-05
dc.date.updated2025-10-30T14:45:41Z
dc.description.abstractTubuloids have become a promising tool for modeling and regenerating kidney disease, although their ability for integration and regeneration in vivo is not well documented. Here, we established, characterized, and compared human tubuloids using two optimized protocols: one involving prior isolation of tubular cells (Crude tubuloids) and the other involving prior isolation of proximal tubular cells (F4 tubuloids). Next, healthy rat-derived tubuloids were established using this protocol. Finally, we compared two strategies for delivering GFP tubuloids to a kidney host: 1) subcapsular/intracortical injection and 2) tubuloid infusion during normothermic preservation in a rat transplantation model and a discarded human kidney. F4 tubuloids achieved a higher level of differentiation state compared to Crude tubuloids. When analyzing tubuloid delivery to the kidney, normothermic perfusion was found to be more efficient than in vivo injection. Moreover, fully developed tubules were observed in the host parenchyma at 1 week and 1 month after infusion during normothermic perfusion represent a potential strategy to enhance the translatability of kidney regenerative therapies into clinical practice to condition kidney grafts and to treat kidney diseases.
dc.format.extent15
dc.format.mimetypeapplication/pdf
dc.identifier.idimarina9481453
dc.identifier.issn1432-2277
dc.identifier.pmid40980193
dc.identifier.urihttps://hdl.handle.net/2445/224366
dc.language.isoEng
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/ti.2025.14747
dc.relation.ispartofTransplant International, 2025, vol. 38, num.14747
dc.relation.urihttps://doi.org/10.3389/ti.2025.14747
dc.rightscc by (c) Montagud Marrahí, Enrique et al., 2025
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
dc.subject.classificationTrasplantament d'òrgans
dc.subject.classificationMalalties del ronyó
dc.subject.classificationMedicina regenerativa
dc.subject.otherTransplantation of organs
dc.subject.otherKidney diseases
dc.subject.otherRegenerative medicine
dc.titleEnhanced Kidney Targeting and Distribution of Tubuloids During Normothermic Perfusion
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
2025_72_TxInt_NMP_Montagud.pdf
Mida:
4.97 MB
Format:
Adobe Portable Document Format